Lonza Group AG (OTCMKTS:LZAGY – Get Free Report) saw a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 22,500 shares, an increase of 5,525.0% from the December 31st total of 400 shares. Based on an average trading volume of 85,500 shares, the days-to-cover ratio is currently 0.3 days.
Wall Street Analyst Weigh In
LZAGY has been the topic of several recent analyst reports. Redburn Atlantic upgraded Lonza Group to a “strong-buy” rating in a research note on Wednesday, November 27th. The Goldman Sachs Group raised shares of Lonza Group to a “strong-buy” rating in a research note on Wednesday, October 9th.
Check Out Our Latest Analysis on Lonza Group
Lonza Group Stock Performance
Lonza Group Company Profile
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.
Further Reading
- Five stocks we like better than Lonza Group
- What is the Nasdaq? Complete Overview with History
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Utilities Stocks Explained – How and Why to Invest in Utilities
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.